Tracheostomy & Ventilator Weaning in Neurocritical Care

ABPN Neurocritical Care Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU

Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU

2 Chapter 2: Cerebral Physiology & Intracranial Dynamics

Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes

3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management

Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions

4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management

Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy

5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management

Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury

6 Chapter 6: Neuropharmacology, Analgesia & Sedation

ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU

7 Bleeding, Thrombosis & Hematologic Emergencies

Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity

8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention

9 Systemic Trauma & Environmental Injury

Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging

10 Cardiac Emergencies & Mechanical Support

IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies

11 Kidney Injury, Acid–Base & Renal Replacement

Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement

12 Systemic Infection & Endocrine Emergencies

Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies

13 Gastrointestinal & Hepatic Emergencies

Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects

14 Chapter 9: Neuroimaging in the Neuro-ICU

Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness

15 Chapter 10: Electrophysiology & Neuromonitoring

Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler

16 Angiography, Electrodiagnosis & CSF Analysis

Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage

17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria

Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria

18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies

Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction

19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage

Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH

20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia

Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations

21 Venous, Spinal & Traumatic Vascular Disease

Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury

22 Chapter 15: Traumatic Brain & Spinal Cord Injury

Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes

23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies

Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure

24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis

Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies

25 Neuroinflammation & Neurooncology

Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies

26 Pregnancy, Transplantation & Pediatric Care

Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care

27 Chapter 18: Neurosurgical & Perioperative Emergencies

Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU

Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor

Tracheostomy & Ventilator Weaning in Neurocritical Care

Key Takeaways Explain This Topic AI

Extubation failure in neurocritical care is predominantly driven by neurological airway failure—impaired bulbar reflexes, depressed consciousness, poor secretional clearance, and weak cough peak flow (< 60 L/min)—rather than traditional cardiopulmonary pump exhaustion.

Traditional weaning parameters (such as the rapid shallow breathing index [RSBI < 105]) have high false-positive rates in neurological patients because they assess respiratory muscle endurance rather than airway protection and clearance.

The landmark SETPOINT2 randomized clinical trial demonstrated that early tracheostomy (within 5 days) in severe acute stroke did not alter 6-month functional neurological outcomes (mRS 0–4) or mortality compared to standard tracheostomy, without establishing a significant reduction in ventilation duration or ICU stay.

Bedside percutaneous dilational tracheostomy (PDT) under real-time bronchoscopic guidance is the preferred procedure in the neuro-ICU; contraindications include severe cervical spine instability, midline neck masses, distorted anatomy, and uncorrectable coagulopathy.

Passy-Muir speaking valve trials require complete endotracheal cuff deflation to prevent fatal asphyxiation, restoring trans-laryngeal airflow, physiological positive end-expiratory pressure, and swallowing dynamics.

Last updated: October 2026

Tracheostomy & Ventilator Weaning in Neurocritical Care

Ventilator weaning and airway management in neurocritical care present a unique diagnostic paradox: patients with severe acute brain injury frequently possess healthy lungs and robust neuromuscular ventilatory drive, easily passing traditional cardiopulmonary weaning criteria, yet they suffer catastrophic extubation failure. Extubation failure in the neuro-ICU occurs in 15 to 35 % 15\text{ to }35\% 15 to 35% of cases—more than double the rate observed in general medical-surgical ICUs—and is associated with a dramatic escalation in hospital-acquired pneumonia, prolonged ICU length of stay, and in-hospital mortality.

The critical difference lies in the mechanism of failure: while general medical patients fail extubation due to respiratory pump exhaustion, diaphragmatic fatigue, or congestive heart failure, neurocritical care patients fail due to neurological airway failure —the inability to protect the subglottic airway from aspiration, pool secretions due to bulbar palsy, or generate sufficient expiratory velocity to clear airway mucus.

The Neuro-Extubation Paradox: Why Traditional Weaning Indices Fail

Traditional weaning parameters evaluate pulmonary mechanics and gas exchange:

Rapid Shallow Breathing Index (RSBI) : Frequency-to-tidal-volume ratio ( f / V t < 105 breaths/min/L f / V_t < 105\text{ breaths/min/L} f / V t < 105 breaths/min/L ).

Spontaneous Breathing Trial (SBT) : 30 to 120 minutes on minimal pressure support ( 5 – 8 cmH 2 O 5\text{--}8\text{ cmH}_2\text{O} 5 – 8 cmH 2 O ) or T-piece.

Negative Inspiratory Force (NIF) : < − 20 to − 30 cmH 2 O <-20\text{ to }-30\text{ cmH}_2\text{O} < − 20 to − 30 cmH 2 O .

In a comatose or severely encephalopathic patient with normal lungs, the brainstem respiratory generator in the pre-Bötzinger complex may drive adequate rhythmic diaphragmatic excursion, easily producing an RSBI of 35 and pristine arterial blood gases during an SBT. However, if the patient lacks voluntary tongue protrusion, possesses absent swallowing reflexes, and has a paralyzed cough, extubation will inevitably lead to upper airway collapse, massive microaspiration of saliva, asphyxiation, and emergency re-intubation.

Objective Clinical Predictors of Extubation Success in ABI

To overcome the limitations of traditional indices, neurocritical care incorporates structured neurological airway assessments:

Assessment Domain Objective Clinical Parameter Favorable Extubation Threshold High Risk of Extubation Failure

Cough Strength Cough Peak Expiratory Flow (CPEF) measured via spirometer attached to ETT ≥ 60 L/min \ge 60\text{ L/min} ≥ 60 L/min < 60 L/min < 60\text{ L/min} < 60 L/min (associated with 5-fold higher risk of failure)

Airway Clearance Endotracheal suctioning frequency ≤ 1 \le 1 ≤ 1 suction event every 2 hours > 1 to 2 > 1\text{ to }2 > 1 to 2 suction events every 2 hours (copious secretions)

Secretional Character Secretion consistency and volume Thin, clear, low volume Thick, tenacious, purulent, abundant secretions

Bulbar Function Spontaneous swallowing, gag, tongue protrusion Presence of spontaneous swallow and active tongue movement to command Absent spontaneous swallowing; pooling of secretions in hypopharynx

Neurological Sensorium Glasgow Coma Scale (GCS) or FOUR Score GCS ≥ 8 – 9 \ge 8\text{--}9 ≥ 8 – 9 ; FOUR brainstem score 4; visual tracking/fixation GCS ≤ 7 – 8 \le 7\text{--}8 ≤ 7 – 8 ; complete unresponsiveness; absent eye tracking

Note

The "four-item airway score" (evaluating cough strength, suctioning frequency, sputum volume, and swallow/command following) reliably predicts neuro-extubation outcome. Never extubate a neuro-ICU patient based on an RSBI < 105 alone without verifying cough peak flow ≥ 60 L/min \ge 60\text{ L/min} ≥ 60 L/min and manageable secretions.

Tracheostomy Timing: Evidence from SETPOINT & SETPOINT2

In patients with severe stroke, traumatic brain injury, or hypoxic-ischemic encephalopathy who exhibit prolonged coma or persistent bulbar failure, the question of when to perform a tracheostomy has been the subject of landmark clinical trials:

The SETPOINT Pilot Trial (2013)

The original SETPOINT (Stroke-Related Early Tracheostomy vs. Prolonged Orotracheal Intubation) pilot trial randomized 60 severe stroke patients to early tracheostomy (within days 1–3) versus standard tracheostomy (days 7–14). The pilot demonstrated a significant reduction in ICU length of stay and 6-month mortality in the early tracheostomy cohort, establishing the hypothesis that early airway control could improve systemic and neurological recovery.

The SETPOINT2 Randomized Clinical Trial (JAMA 2022)

To definitively test this hypothesis, the multicenter SETPOINT2 trial randomized 382 mechanically ventilated patients with severe acute brain injury (ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage) with predicted prolonged ventilation across 26 neurocritical care centers:

Intervention Arm : Early tracheostomy performed on or before ICU Day 5 .

Control Arm : Standard tracheostomy performed from ICU Day 10 onward if extubation readiness could not be achieved.

SETPOINT2: Early tracheostomy by day 5 did not significantly improve six-month functional outcome compared with ongoing weaning and standard tracheostomy if needed from day 10. The trial did not establish significant reductions in duration of ventilation or ICU stay. Individualize timing from airway protection, trajectory, procedural risk, and patient goals; do not promise a survival or length-of-stay benefit.

Procedural Selection: Bedside Percutaneous vs. Surgical Tracheostomy

In modern neurocritical care, bedside percutaneous dilational tracheostomy (PDT) using the Ciaglia single-dilator technique under continuous flexible bronchoscopic guidance has largely replaced open surgical tracheostomy:

Procedural Parameter Bedside Percutaneous Tracheostomy (PDT) Open Surgical Tracheostomy
Setting Bedside in the Neuro-ICU Operating room (requires intra-hospital transport)

Wound Complications Significantly lower stomal infection rates; snug stoma fit Higher rate of minor peristomal oozing and soft-tissue wound infection

Cost & Logistics Cost-effective; avoids OR scheduling delays and transport risks Higher cost; requires operating room staff and anesthesia

Anatomical Limitations Requires palpable landmarks; relative contraindication in large goiters Preferred in morbid obesity, distorted anatomy, or aberrant vessels

Contraindications to Bedside PDT in Neurocritical Care

Severe Cervical Spine Instability : PDT requires moderate neck extension to bring the trachea forward; in patients with unstable cervical fractures that cannot tolerate neck manipulation, open surgical tracheostomy without neck extension is indicated.

Anatomical Obstacles : Massive goiter, overlying midline neck mass, aberrant pulsatile vascular structures (e.g., high-riding innominate artery), or severe scarring from prior neck surgery.

Uncorrectable Coagulopathy : Platelet count < 50,000 / μ L < 50{,}000/\mu\text{L} < 50 , 000/ μ L or INR > 1.5 – 1.8 > 1.5\text{--}1.8 > 1.5 – 1.8 should be corrected prior to intervention.

Emergency Airway Needs : PDT is an elective procedure; it is never indicated for emergent airway rescue in a "cannot intubate, cannot oxygenate" crisis.

Procedural Complications & The Neuro-Specific ICP Hazard

Procedural complications of PDT include tracheal ring fracture, paratracheal false passage, posterior tracheal wall laceration (which can form a catastrophic tracheoesophageal fistula), and acute hemorrhage from the thyroid isthmus or anterior jugular veins.

The ICP Spike Hazard : During bedside PDT, introducing a flexible bronchoscope through an endotracheal tube (especially ≤ 8.0 mm \le 8.0\text{ mm} ≤ 8.0 mm internal diameter) severely obstructs the cross-sectional area for expiratory airflow. This generates high intrinsic PEEP, dynamic hyperinflation, and acute hypoventilation. The resulting rapid hypercapnia ( P a C O 2 PaCO_2 P a C O 2 spikes) and thoracic venous congestion frequently provoke acute, severe ICP elevations in patients with intracranial hypertension. Practitioners must monitor ICP continuously, keep bronchoscopic occlusion times brief, pre-oxygenate, and ventilate adequately around the scope.

Weaning Protocols, Speaking Valves & Decannulation

Once a patient with a tracheostomy demonstrates neurological stabilization, structured rehabilitation proceeds:

Passy-Muir Speaking Valve (PMV) Trials

The Passy-Muir valve is a one-way valve that opens during inspiration (allowing air to enter through the tracheostomy tube) and closes during expiration, forcing exhaled air upward through the vocal cords and upper airway.

Warning

The tracheostomy tube cuff MUST BE COMPLETELY DEFLATED prior to attaching a Passy-Muir speaking valve. Leaving the cuff inflated while placing a one-way speaking valve completely blocks the expiratory airway, resulting in immediate, catastrophic asphyxiation and tension pneumothorax.

When correctly applied with the cuff deflated, the PMV restores subglottic airway pressure ( 5 – 10 cmH 2 O 5\text{--}10\text{ cmH}_2\text{O} 5 – 10 cmH 2 O ), which significantly improves swallowing mechanics, reduces pharyngeal pooling, improves cough effectiveness, and facilitates verbal communication.

Objective Decannulation Criteria

A patient is safe for decannulation when they meet all of the following criteria:

Resolution of Primary Insult : Intracranial pressure is normalized, and the acute phase of brain injury is resolved.

Ventilator Independence : Completely weaned from mechanical ventilation for ≥ 24 to 48 hours \ge 24\text{ to }48\text{ hours} ≥ 24 to 48 hours .

Airway Patency : Direct endoscopic or laryngoscopic visualization confirms absence of clinically significant tracheal stenosis, malacia, or vocal cord paralysis.

Secretion Management : Requires tracheal suctioning no more than once or twice per 8-hour nursing shift.

Airway Protection & Cough : Demonstrates an effective voluntary or reflexive cough with cough peak expiratory flow ≥ 60 L/min \ge 60\text{ L/min} ≥ 60 L/min .

Capping Trial : Tolerates a fully capped tracheostomy tube (or speaking valve) continuously for ≥ 24 hours \ge 24\text{ hours} ≥ 24 hours (including sleep) without tachypnea, stridor, hypoxemia, or secretional distress.